Immunologic response to mistletoe extract (Viscum album L.) after conventional treatment in patients with operable breast cancer

Gil Soo Son, Woo Sang Ryu, Hoon Yub Kim, Sang- Uk Woo, Kyong Hwa Park, Jeoung Won Bae

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose: To reduce the side effects and improve the effectiveness of standard chemoradiation therapy, many complementary or alternative medicines have been tried. However, little is known about its immunologic effects in breast cancer patients. The aim of this study was to assess the immunologic effects of mistletoe extract (Viscum album L., VAE) in patients with early breast cancer after surgery followed by standard adjuvant chemoradiation therapy. Methods: A total 20 patients with early breast cancer treated with breast conserving surgery followed conventional chemoradiation therapy. Ten of these patients received subcutaneous injections of VAE for 7 weeks. IL-2, IL-4, IL-6, IL-10, TGF-β, and IFN-γ levels in serum samples were measured in all patients. Results: The concentrations of IL-2, IL 4, IL-10, and TGF-β were not significantly changed between before and after VAE treatment in both test and control group. The concentration of IL-6 in the test group was increased from 8.19±1.75 pg/mL to 9.86±1.46 pg/mL after treatment (p=0.013). The concentration of IFN-γ in the test group was remarkably increased from 91.76±17.16 pg/mL to 167.42±66.61 pg/mL after treatment (p=0.009). Conclusion: Significant increases in the concentration of IL-6 and IFN-γ were observed after VAE treatment. These results suggest that VAE treatment can stimulate immune responses, especially cell mediated immunity in immune-compromised patients received the chemoradiation for breast cancer.

Original languageEnglish
Pages (from-to)14-18
Number of pages5
JournalJournal of Breast Cancer
Volume13
Issue number1
DOIs
Publication statusPublished - 2010 Mar 1

Fingerprint

Viscum album
Mistletoe
Breast Neoplasms
Interleukin-6
Therapeutics
Complementary Therapies
Interleukin-4
Interleukin-10
Interleukin-2
Segmental Mastectomy
Subcutaneous Injections
Cellular Immunity
Control Groups

Keywords

  • Breast neoplasms
  • Immunology
  • Mistletoe
  • Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{7f03221a69e346d49ef723d36b26c924,
title = "Immunologic response to mistletoe extract (Viscum album L.) after conventional treatment in patients with operable breast cancer",
abstract = "Purpose: To reduce the side effects and improve the effectiveness of standard chemoradiation therapy, many complementary or alternative medicines have been tried. However, little is known about its immunologic effects in breast cancer patients. The aim of this study was to assess the immunologic effects of mistletoe extract (Viscum album L., VAE) in patients with early breast cancer after surgery followed by standard adjuvant chemoradiation therapy. Methods: A total 20 patients with early breast cancer treated with breast conserving surgery followed conventional chemoradiation therapy. Ten of these patients received subcutaneous injections of VAE for 7 weeks. IL-2, IL-4, IL-6, IL-10, TGF-β, and IFN-γ levels in serum samples were measured in all patients. Results: The concentrations of IL-2, IL 4, IL-10, and TGF-β were not significantly changed between before and after VAE treatment in both test and control group. The concentration of IL-6 in the test group was increased from 8.19±1.75 pg/mL to 9.86±1.46 pg/mL after treatment (p=0.013). The concentration of IFN-γ in the test group was remarkably increased from 91.76±17.16 pg/mL to 167.42±66.61 pg/mL after treatment (p=0.009). Conclusion: Significant increases in the concentration of IL-6 and IFN-γ were observed after VAE treatment. These results suggest that VAE treatment can stimulate immune responses, especially cell mediated immunity in immune-compromised patients received the chemoradiation for breast cancer.",
keywords = "Breast neoplasms, Immunology, Mistletoe, Therapy",
author = "Son, {Gil Soo} and Ryu, {Woo Sang} and Kim, {Hoon Yub} and Woo, {Sang- Uk} and Park, {Kyong Hwa} and Bae, {Jeoung Won}",
year = "2010",
month = "3",
day = "1",
doi = "10.4048/jbc.2010.13.1.14",
language = "English",
volume = "13",
pages = "14--18",
journal = "Journal of Breast Cancer",
issn = "1738-6756",
publisher = "Korean Breast Cancer Society",
number = "1",

}

TY - JOUR

T1 - Immunologic response to mistletoe extract (Viscum album L.) after conventional treatment in patients with operable breast cancer

AU - Son, Gil Soo

AU - Ryu, Woo Sang

AU - Kim, Hoon Yub

AU - Woo, Sang- Uk

AU - Park, Kyong Hwa

AU - Bae, Jeoung Won

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Purpose: To reduce the side effects and improve the effectiveness of standard chemoradiation therapy, many complementary or alternative medicines have been tried. However, little is known about its immunologic effects in breast cancer patients. The aim of this study was to assess the immunologic effects of mistletoe extract (Viscum album L., VAE) in patients with early breast cancer after surgery followed by standard adjuvant chemoradiation therapy. Methods: A total 20 patients with early breast cancer treated with breast conserving surgery followed conventional chemoradiation therapy. Ten of these patients received subcutaneous injections of VAE for 7 weeks. IL-2, IL-4, IL-6, IL-10, TGF-β, and IFN-γ levels in serum samples were measured in all patients. Results: The concentrations of IL-2, IL 4, IL-10, and TGF-β were not significantly changed between before and after VAE treatment in both test and control group. The concentration of IL-6 in the test group was increased from 8.19±1.75 pg/mL to 9.86±1.46 pg/mL after treatment (p=0.013). The concentration of IFN-γ in the test group was remarkably increased from 91.76±17.16 pg/mL to 167.42±66.61 pg/mL after treatment (p=0.009). Conclusion: Significant increases in the concentration of IL-6 and IFN-γ were observed after VAE treatment. These results suggest that VAE treatment can stimulate immune responses, especially cell mediated immunity in immune-compromised patients received the chemoradiation for breast cancer.

AB - Purpose: To reduce the side effects and improve the effectiveness of standard chemoradiation therapy, many complementary or alternative medicines have been tried. However, little is known about its immunologic effects in breast cancer patients. The aim of this study was to assess the immunologic effects of mistletoe extract (Viscum album L., VAE) in patients with early breast cancer after surgery followed by standard adjuvant chemoradiation therapy. Methods: A total 20 patients with early breast cancer treated with breast conserving surgery followed conventional chemoradiation therapy. Ten of these patients received subcutaneous injections of VAE for 7 weeks. IL-2, IL-4, IL-6, IL-10, TGF-β, and IFN-γ levels in serum samples were measured in all patients. Results: The concentrations of IL-2, IL 4, IL-10, and TGF-β were not significantly changed between before and after VAE treatment in both test and control group. The concentration of IL-6 in the test group was increased from 8.19±1.75 pg/mL to 9.86±1.46 pg/mL after treatment (p=0.013). The concentration of IFN-γ in the test group was remarkably increased from 91.76±17.16 pg/mL to 167.42±66.61 pg/mL after treatment (p=0.009). Conclusion: Significant increases in the concentration of IL-6 and IFN-γ were observed after VAE treatment. These results suggest that VAE treatment can stimulate immune responses, especially cell mediated immunity in immune-compromised patients received the chemoradiation for breast cancer.

KW - Breast neoplasms

KW - Immunology

KW - Mistletoe

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=77953196147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953196147&partnerID=8YFLogxK

U2 - 10.4048/jbc.2010.13.1.14

DO - 10.4048/jbc.2010.13.1.14

M3 - Article

VL - 13

SP - 14

EP - 18

JO - Journal of Breast Cancer

JF - Journal of Breast Cancer

SN - 1738-6756

IS - 1

ER -